Skip to main content

Volume 2 Supplement 2

Abstracts from the 1st Immunotherapy of Cancer Conference (ITOC1)

  • Invited speaker presentation
  • Open access
  • Published:

S47. Tumour infiltrating lymphocytes - a predictive marker?


To date the anatomic extent of tumor (TNM classifications) has been by far the most important factors to predict the prognosis of cancer patients. However, this classification provides limited prognostic information in estimating the outcome in cancer and does not predict response to therapy.

Materials and methods

large-scale approaches, and quantitative measurements, we evaluated the importance of the host-immune response within human tumors.


We showed that tumors from human colorectal cancer with a high density of infiltrating memory and effector memory T-cells (TEM) are less likely to disseminate to lymphovascular and perineural structures and to regional lymph-nodes. We showed that the combination of immune parameters associating the nature, the density, the functional orientation and the location of immune cells within the tumor was essential to accurately define the impact of the local host immune reaction on patients prognosis. We defined these parameters as the “immune contexture”, and factors modulating it will be discussed. Based on the immune contexture, a standardized, simple and powerful immune stratification system, termed the “Immunoscore”, was delineated that may bear a prognostic power superior to that of the currently used cancer staging system. Tumor invasion parameters were statistically dependent on the host-immune reaction. A worldwide Immunoscore consortium is testing the prognostic value of the Immunoscore, using a standardized assay to routinely measure the immune status of a cancer patient.


The functional orientation of the immune contexture is characterized by immune signatures qualitatively similar to those predicting response to immunotherapy, Thus, the continuum of immune response existing, spanning a balance between tumor cell growth and elimination, will be discussed.

Author information

Authors and Affiliations


Rights and permissions

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Cite this article

Galon, J. S47. Tumour infiltrating lymphocytes - a predictive marker?. j. immunotherapy cancer 2 (Suppl 2), I10 (2014).

Download citation

  • Published:

  • DOI: